Clinical Trial Update: An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 trial of low-dose all-trans retinoic acid in primary sclerosing cholangitis was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)

Snippet

Sponsor: Yale University | Conditions: Cholangitis, Sclerosing | Phase 2 | Status: TERMINATED | Results posted: 2021-08-09